• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

明确前列腺特异性抗原(PSA)灰色地带:PSA临界值患者的管理

Clarifying the PSA grey zone: The management of patients with a borderline PSA.

作者信息

Ross Talisa, Ahmed Kamran, Raison Nicholas, Challacombe Ben, Dasgupta Prokar

机构信息

Guy's Hospital, King's College London, London, UK.

出版信息

Int J Clin Pract. 2016 Nov;70(11):950-959. doi: 10.1111/ijcp.12883. Epub 2016 Sep 27.

DOI:10.1111/ijcp.12883
PMID:27672001
Abstract

INTRODUCTION

Prostate specific antigen is a marker for prostate cancer and a key diagnostic tool, yet when to refer patients with a borderline PSA is currently unclear. This review describes how to assess a patient with borderline PSA and provides an algorithm for management.

METHODS

Current literature on reference values, factors affecting PSA, indications for referral, non-invasive investigations and the role of MRI were reviewed. Medline and EMBASE were searched using MeSH terms.

RESULTS

The literature suggests that a PSA of over 1.5 ng/mL should be used as a cut-off to consider further testing for all age groups. There is strong evidence to show that adjuncts are useful when interpreting PSA results, most notably percentage free PSA and proPSA. Considerable weighting should also be given to the ERSPC risk calculator when deciding when to refer. Multi-parametric MRI is valuable in closely examining suspicious lesions to reduce the number of negative biopsies. MRI fusion biopsy (TRUS, transrectal ultrasonography or transperineal) should be considered over standard TRUS biopsy to detect more clinically significant disease.

CONCLUSIONS

Management of borderline PSA is not straightforward. A cut-off of 1.5 ng/mL should be used in conjunction with digital rectal exam, risk calculation and PSA adjuncts. Imaging and biopsy should utilise mpMRI to achieve improved diagnosis of clinically significant prostate cancer, with fewer unnecessary investigations.

摘要

引言

前列腺特异性抗原是前列腺癌的标志物和关键诊断工具,但目前尚不清楚何时应转诊前列腺特异性抗原处于临界值的患者。本综述描述了如何评估前列腺特异性抗原处于临界值的患者,并提供了一种管理算法。

方法

对有关参考值、影响前列腺特异性抗原的因素、转诊指征、非侵入性检查以及磁共振成像作用的当前文献进行了综述。使用医学主题词在Medline和EMBASE中进行检索。

结果

文献表明,对于所有年龄组,应将前列腺特异性抗原超过1.5 ng/mL作为进一步检查的临界值。有强有力的证据表明,在解释前列腺特异性抗原结果时,辅助指标很有用,最显著的是游离前列腺特异性抗原百分比和前列腺特异性抗原前体。在决定何时转诊时,也应充分考虑欧洲前列腺癌筛查随机对照试验风险计算器。多参数磁共振成像对于仔细检查可疑病变以减少阴性活检数量很有价值。与标准经直肠超声活检相比,应考虑使用磁共振成像融合活检(经直肠超声或经会阴)以检测更多具有临床意义的疾病。

结论

前列腺特异性抗原处于临界值的管理并不简单。1.5 ng/mL的临界值应与直肠指检、风险计算和前列腺特异性抗原辅助指标结合使用。成像和活检应利用多参数磁共振成像来更好地诊断具有临床意义的前列腺癌,同时减少不必要的检查。

相似文献

1
Clarifying the PSA grey zone: The management of patients with a borderline PSA.明确前列腺特异性抗原(PSA)灰色地带:PSA临界值患者的管理
Int J Clin Pract. 2016 Nov;70(11):950-959. doi: 10.1111/ijcp.12883. Epub 2016 Sep 27.
2
Repeat transrectal ultrasound biopsies with additional targeted cores according to results of functional prostate MRI detects high-risk prostate cancer in patients with previous negative biopsy and increased PSA - a pilot study.根据功能前列腺 MRI 的结果,对先前阴性活检和 PSA 升高的患者进行重复经直肠超声活检和额外靶向核心检测,可发现高危前列腺癌——一项试点研究。
Anticancer Res. 2012 Mar;32(3):1087-92.
3
Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients.前列腺影像报告和数据系统(PI-RADS)评分与前列腺特异性抗原(PSA)密度相结合可预测初次接受前列腺穿刺活检患者的活检结果。
BJU Int. 2017 Feb;119(2):225-233. doi: 10.1111/bju.13465. Epub 2016 Apr 1.
4
[Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate].[超声引导下经直肠前列腺穿刺活检在前列腺癌诊断中的阳性率]
Arch Esp Urol. 1995 Jul-Aug;48(6):587-94.
5
[Utility of prostate specific antigen (PSA) density in detecting prostate cancer in men showing gray zone serum PSA levels].[前列腺特异性抗原(PSA)密度在血清PSA水平处于灰色区间男性前列腺癌检测中的应用]
Hinyokika Kiyo. 1997 Jan;43(1):13-8.
6
The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.筛查试验在前列腺癌检测中的价值。第二部分:游离/总前列腺特异性抗原分析比值、年龄特异性参考范围及前列腺特异性抗原密度的回顾性分析
Urology. 1995 Dec;46(6):779-84. doi: 10.1016/S0090-4295(99)80343-4.
7
[Evaluation of methods of detection for prostate neoplasm].[前列腺肿瘤检测方法的评估]
Zhonghua Zhong Liu Za Zhi. 2001 Jan;23(1):64-6.
8
In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?对于既往前列腺活检结果为阴性但磁共振成像显示有可疑病变的患者,除了靶向活检外,是否仍需要进行12针活检?
BJU Int. 2015 Apr;115(4):562-70. doi: 10.1111/bju.12938.
9
Multiparametric MRI in detection and staging of prostate cancer.多参数磁共振成像在前列腺癌检测与分期中的应用
Dan Med J. 2017 Feb;64(2).
10
Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA < 10 ng/mL?3特斯拉盆腔相控阵多参数磁共振成像能否避免血清前列腺特异抗原(PSA)<10 ng/mL患者进行不必要的重复前列腺穿刺活检?
Clin Genitourin Cancer. 2015 Feb;13(1):e27-30. doi: 10.1016/j.clgc.2014.06.013. Epub 2014 Jun 21.

引用本文的文献

1
The Association Between Borderline Personality Disorder Symptoms and Social Behaviour Among University Students.大学生边缘型人格障碍症状与社交行为之间的关联
Medicina (Kaunas). 2025 Aug 14;61(8):1465. doi: 10.3390/medicina61081465.
2
Analysis of gray zone PSA and PSAD correlated with PIRADS v2.1 in the MRI-US fusion prostate biopsy era: a retrospective bi-centre study.MRI-US融合前列腺活检时代灰色地带前列腺特异性抗原(PSA)和前列腺特异性抗原密度(PSAD)与前列腺影像报告和数据系统(PIRADS)v2.1的相关性分析:一项回顾性双中心研究
Int Urol Nephrol. 2025 May 8. doi: 10.1007/s11255-025-04551-w.
3
Serum levels of prostate specific antigen, free PSA, [-2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy.
良性前列腺增生药物治疗患者的血清前列腺特异性抗原、游离前列腺特异性抗原、[-2]前列腺特异性抗原前体、游离前列腺特异性抗原/总前列腺特异性抗原比值、前列腺健康指数及游离前列腺特异性抗原的糖基化模式
Prostate. 2025 Jan;85(1):65-72. doi: 10.1002/pros.24801. Epub 2024 Sep 27.
4
Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers.全蛋白质组学孟德尔随机化研究提示常见癌症的治疗靶点。
J Transl Med. 2023 Sep 21;21(1):646. doi: 10.1186/s12967-023-04525-5.
5
Diagnostic Efficacy of PSMA and PSCA mRNAs Combined to PSA in Prostate Cancer Patients.PSMA 和 PSCA mRNA 联合 PSA 对前列腺癌患者的诊断效能。
Asian Pac J Cancer Prev. 2023 Jan 1;24(1):223-229. doi: 10.31557/APJCP.2023.24.1.223.
6
A smart, practical, deep learning-based clinical decision support tool for patients in the prostate-specific antigen gray zone: model development and validation.一种基于智能、实用的深度学习的前列腺特异性抗原灰区患者临床决策支持工具:模型开发与验证。
J Am Med Inform Assoc. 2022 Oct 7;29(11):1949-1957. doi: 10.1093/jamia/ocac141.
7
Role of glutathione-S-transferase gene P1 in the diagnosis of prostate cancer in patients with 'grey level' prostate-specific antigen values.谷胱甘肽-S-转移酶基因P1在“灰度”前列腺特异性抗原值患者前列腺癌诊断中的作用
Exp Ther Med. 2022 Jul 26;24(3):591. doi: 10.3892/etm.2022.11528. eCollection 2022 Sep.
8
Diagnostic accuracy of prostate-specific antigen below 4 ng/mL as a cutoff for diagnosing prostate cancer in a hospital setting: A systematic review and meta-analysis.以 4ng/mL 为截断值的前列腺特异性抗原在医院环境中诊断前列腺癌的诊断准确性:系统评价和荟萃分析。
Investig Clin Urol. 2022 May;63(3):251-261. doi: 10.4111/icu.20210429.
9
Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool.微小RNA组失调揭示肥胖与前列腺癌之间的相互作用:miR-107作为个性化诊断和治疗工具
Mol Ther Nucleic Acids. 2022 Feb 12;27:1164-1178. doi: 10.1016/j.omtn.2022.02.010. eCollection 2022 Mar 8.
10
Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA.两种新型类神经酰胺分子和miR-5100水平作为生物标志物可改善灰色区域前列腺特异性抗原(PSA)中前列腺癌的预测。
Front Oncol. 2021 Nov 19;11:769158. doi: 10.3389/fonc.2021.769158. eCollection 2021.